CAMBRIDGE NEWS: CONGENICA DEAL WITH NHSA TO HELP CUT DIAGNOSIS TIMES FOR RARE GENETIC DISEASES
CAMBRIDGE NEWS: CONGENICA DEAL WITH NHSA TO HELP CUT DIAGNOSIS TIMES FOR RARE GENETIC DISEASES
20th May 2016
A Cambridge company’s technology which can cut the diagnosis times for rare genetic diseases is being made available on the NHS.
Related News Articles
PHOTO GALLERY: A week in Amsterdam for HLTH 2026
View photos from a week in Amsterdam for HLTH 2026
Read the articleLandmark MRC-funded BEACON programme will support clinical academic careers across the North
Newcastle University, supported by the Northern Health Science Alliance, will lead a major new Medical Research Council (MRC) programme designed to strengthen clinical academic careers and research leadership across the North of England.
Read the articleStatement from Chief Executive Officer following the Autumn Budget 2025
The NHSA's CEO has written a response following the Chancellor's Budget announcement
Read the article